back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-07 21:03 Tx date 2024-10-03 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5.00
-1,000 vol $0.005 each |
633,000 | |
| Filed 2024-10-01 16:55 Tx date 2024-09-30 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5.00
-1,000 vol $0.005 each |
634,000 | |
| Filed 2024-09-23 14:29 Tx date 2024-09-19 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5.00
-1,000 vol $0.005 each |
635,000 | |
| Filed 2024-09-11 17:36 Tx date 2024-09-10 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,820
-364,000 vol $0.005 each |
636,000 | |
| Filed 2024-08-29 15:10 Tx date 2024-08-27 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-600,000 vol $0.005 each |
1,000,000 | |
| Filed 2024-08-29 15:06 Tx date 2024-08-26 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-600,000 vol $0.005 each |
1,600,000 | |
| Filed 2024-06-24 16:31 Tx date 2024-06-07 |
$WBIO
WPD Pharmaceuticals Inc. |
Olejniczak, Mariusz
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$32,856
+657,120 vol $0.05 each |
1,334,401 | |
| Filed 2024-06-14 12:16 Tx date 2024-06-07 |
$WBIO
WPD Pharmaceuticals Inc. |
Rzepczyk, Teresa
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$6,600
+132,000 vol $0.05 each |
132,000 | |
| Filed 2023-04-06 14:57 Tx date 2023-03-23 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Holder: Caelum Finance Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,200,000 | ||
| Filed 2023-04-06 14:54 Tx date 2023-03-23 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-06 14:53 Tx date 2023-03-23 |
$WBIO
WPD Pharmaceuticals Inc. |
Carmichel, Constantine
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-27 15:08 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Corcoran, Liam Lake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$602,000
+700,000 vol $0.86 each |
||
| Filed 2020-07-27 15:07 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Corcoran, Liam Lake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$602,000
+700,000 vol $0.86 each |
||
| Filed 2020-01-17 17:06 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Rzepczyk, Teresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$172,000
+200,000 vol $0.86 each |
200,000 | |
| Filed 2020-01-17 16:58 Tx date 2019-04-23 |
$WBIO
WPD Pharmaceuticals Inc. |
Rzepczyk, Teresa
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 20:12 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Novak, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2020-01-16 20:11 Tx date 2019-12-20 |
$WBIO
WPD Pharmaceuticals Inc. |
Novak, Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 20:08 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Olejniczak, Mariusz
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2020-01-16 20:08 Tx date 2019-12-20 |
$WBIO
WPD Pharmaceuticals Inc. |
Olejniczak, Mariusz
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 20:02 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Klemp, Walter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
750,000 | |
| Filed 2020-01-16 20:02 Tx date 2019-12-20 |
$WBIO
WPD Pharmaceuticals Inc. |
Klemp, Walter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 19:57 Tx date 2020-01-13 |
$WBIO
WPD Pharmaceuticals Inc. |
Corcoran, Liam Lake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
700,000 | |
| Filed 2020-01-16 19:54 Tx date 2017-07-01 |
$WBIO
WPD Pharmaceuticals Inc. |
Corcoran, Liam Lake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 19:24 Tx date 2020-01-14 |
$WBIO
WPD Pharmaceuticals Inc. |
Cherry, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$430,000
+500,000 vol $0.86 each |
500,000 | |
| Filed 2020-01-16 19:22 Tx date 2019-12-27 |
$WBIO
WPD Pharmaceuticals Inc. |
Cherry, Christopher
5 - Senior Officer of Issuer
Holder: Cherry Consulting Ltd. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 19:22 Tx date 2019-12-27 |
$WBIO
WPD Pharmaceuticals Inc. |
Cherry, Christopher
5 - Senior Officer of Issuer
Holder: Cherry Consulting Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 19:18 Tx date 2019-12-27 |
$WBIO
WPD Pharmaceuticals Inc. |
Cherry, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-16 19:18 Tx date 2019-12-27 |
$WBIO
WPD Pharmaceuticals Inc. |
Cherry, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
23,705 | ||
| Filed 2019-12-30 16:16 Tx date 2019-04-23 |
$WBIO
Westcot Ventures Corp. |
Rzepczyk, Teresa
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|